rethinkPeptides Search
Menu
RethinkPeptides

GLP-1 Safety

Explore peptide research and guides on glp-1 safety.

GLP-1 Safety

Gastroparesis and GLP-1 Drugs: The Evidence

GLP-1 agonists delay gastric emptying by design. When does slowed digestion cross into gastroparesis, how common is it, and what the anesthesia data shows.

GLP-1 Safety

GLP-1 Agonists and Pancreatitis: The Evidence

A meta-analysis of 62 RCTs found a small pancreatitis signal with GLP-1 drugs that vanished when accounting for co-medications. Here is what the data shows.

GLP-1 Safety

GLP-1 Agonists and Retinopathy

Semaglutide raised retinopathy concerns in SUSTAIN-6, but the risk appears tied to rapid glucose lowering, not the drug itself. Here is the full evidence.

GLP-1 Safety

GLP-1 Agonists and Thyroid Cancer Risk

GLP-1 receptor agonists cause thyroid C-cell tumors in rodents but human evidence remains conflicting. Seven studies reveal what the data actually shows.